Ghost Tree Capital, LLC Cti Biopharma Corp Transaction History

Ghost Tree Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.2 - $6.01 $630,000 - $901,500	150,000 Added 8.11%	2,000,000 $8.4 Million
Q4 2022 Feb 14, 2023	SELL	$4.45 - $6.17 $667,500 - $925,500	-150,000 Reduced 7.5%	1,850,000 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $6.43 Million - $8.92 Million	1,200,000 Added 150.0%	2,000,000 $11.6 Million
Q2 2022 Aug 15, 2022	SELL	$3.55 - $6.27 $1.78 Million - $3.14 Million	-500,000 Reduced 38.46%	800,000 $4.78 Million
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $190,000 - $523,000	100,000 Added 8.33%	1,300,000 $6.07 Million

Q4 2021 Feb 16, 2022	SELL	$1.44 - $2.86 $576,000 - $1.14 Million	-400,000 Reduced 25.0%	1,200,000 $2.98 Million
Q2 2021 Aug 11, 2021	BUY	$2.16 - $2.62 $1.84 Million - $2.23 Million	850,000 Added 113.33%	1,600,000 $4 Million
Q4 2020 Feb 16, 2021	BUY	$2.48 - $3.8 $1.86 Million - $2.85 Million	750,000 New	750,000 $2.42 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.